Xuan Zou Selected Research

Xuan Zou Research Topics

Disease

20	Neoplasms (Cancer) 08/2022 - 06/2014
6	COVID-19 01/2022 - 12/2020
6	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2018
5	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 08/2012
4	Inflammation (Inflammations) 08/2022 - 04/2014
4	Infections 01/2022 - 10/2017
4	Knee Osteoarthritis 01/2021 - 01/2019
4	Lung Neoplasms (Lung Cancer) 05/2020 - 02/2016
3	Insulin Resistance 01/2022 - 10/2014
3	Cognitive Dysfunction 11/2021 - 10/2014
3	Virus Diseases (Viral Diseases) 07/2021 - 01/2018
3	Nasopharyngeal Carcinoma 02/2020 - 12/2017
3	Obesity 01/2019 - 10/2014
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2022 - 02/2014
2	Hypersensitivity (Allergy) 02/2022 - 01/2020
2	Bietti Crystalline Dystrophy 01/2022 - 01/2020
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2022
2	Ileus 01/2022 - 10/2020
2	Atrophy 01/2021 - 01/2020
2	Weight Loss (Weight Reduction) 01/2021 - 01/2019
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 01/2019
2	Endometrial Neoplasms (Endometrial Cancer) 01/2021 - 10/2020
2	Papillary Thyroid Cancer 11/2020 - 04/2019
2	Macular Degeneration (Age-Related Maculopathy) 01/2018 - 11/2013
1	Hypertension (High Blood Pressure) 11/2022
1	Autoimmune Diseases (Autoimmune Disease) 03/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 03/2022
1	Hyperuricemia 01/2022
1	Rectal Neoplasms (Rectal Cancer) 01/2022
1	Postoperative Pain 01/2022
1	Flatulence 01/2022
1	Heart Failure 01/2022
1	Postoperative Nausea and Vomiting (PONV) 01/2022
1	Myocardial Infarction 01/2022
1	Microsatellite Instability 01/2022
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022
1	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 01/2022
1	Cerebral Hemorrhage 11/2021
1	Hemorrhagic Stroke 11/2021
1	Bacterial Infections (Bacterial Infection) 07/2021
1	Coinfection 07/2021

Drug/Important Bio-Agent (IBA)

15	MicroRNAs (MicroRNA)IBA 03/2022 - 01/2019
15	Biomarkers (Surrogate Marker)IBA 06/2021 - 12/2017
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2011
7	LipidsIBA 01/2022 - 04/2014
5	Messenger RNA (mRNA)IBA 03/2022 - 01/2011
5	salicylhydroxamic acid (SHAM)IBA 01/2022 - 01/2019
4	RNA (Ribonucleic Acid)IBA 11/2022 - 12/2020
4	Triglycerides (Triacylglycerol)IBA 01/2022 - 08/2014
3	Immunoglobulin G (IgG)IBA 01/2022 - 01/2021
3	EnzymesIBA 01/2022 - 08/2012
3	Mitochondrial DNA (mtDNA)IBA 01/2021 - 02/2015
2	Interleukin-6 (Interleukin 6)IBA 11/2022 - 10/2020
2	Insulin (Novolin)FDA Link 03/2022 - 01/2019
2	MetalsIBA 02/2022 - 01/2022
2	Neutralizing AntibodiesIBA 01/2022 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 12/2018
2	CholesterolIBA 11/2021 - 10/2014
2	Retinaldehyde (Retinal)IBA 01/2021 - 01/2020
2	Antiviral Agents (Antivirals)IBA 01/2021 - 10/2020
2	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 01/2016
2	Viral RNAIBA 12/2020 - 01/2018
2	Therapeutic UsesIBA 01/2020 - 06/2014
2	Retinal Pigments (Pigments, Visual)IBA 01/2020 - 01/2018
2	Connexin 43 (Connexin43)IBA 01/2020 - 02/2016
2	CytokinesIBA 01/2018 - 10/2014
2	3,4-dihydroxyphenylethanol (hydroxytyrosol)IBA 02/2014 - 08/2012
2	Pharmaceutical PreparationsIBA 02/2014 - 11/2013
1	Omalizumab (Xolair)FDA Link 11/2022
1	Monoclonal AntibodiesIBA 11/2022
1	Immunoglobulin E (IgE)IBA 11/2022
1	anti-IgE antibodiesIBA 11/2022
1	betaninIBA 08/2022
1	Matrix Metalloproteinases (MMPs)IBA 08/2022
1	CytosineIBA 06/2022
1	Butyrates (Butyrate)IBA 03/2022
1	Glucagon-Like Peptide 1 (GLP 1)IBA 03/2022
1	Transforming Growth Factor-beta Type II ReceptorIBA 03/2022
1	Deoxyribonucleases (DNase)FDA Link 02/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022
1	Dynamins (Dynamin)IBA 01/2022
1	InflammasomesIBA 01/2022
1	NLR ProteinsIBA 01/2022
1	Arginine (L-Arginine)FDA Link 01/2022
1	FumaratesIBA 01/2022
1	Analgesics (Analgesic Drugs)IBA 01/2022
1	Rituximab (Mabthera)FDA Link 01/2022
1	Phosphatidylethanolamines (Cephalins)IBA 01/2022
1	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 01/2022
1	ImmunosorbentsIBA 01/2022
1	PlasmalogensIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Scopolamine (Hyoscine)FDA Link 11/2021

Therapy/Procedure

4	Therapeutics 03/2021 - 01/2016
2	Electroacupuncture 01/2022 - 10/2020
2	Acupuncture Therapy 01/2021 - 07/2019
1	Neoadjuvant Therapy 01/2022
1	Length of Stay 01/2022